- Title
- A Phase II Study of Surgical Excision, Temozolomide, Radiotherapy, and Anti-EGFR Radioimmunotherapy (EXTRA) as Adjuvant Therapy in High-grade Gliomas
- Creators
- L.C. Daugherty - Hahnemann University HospitalS. Morales - Hahnemann University Hospitalb. fisher - Hahnemann University HospitalL. Li - Fox Chase Cancer CenterJ. Kim - City Of Hope National Medical CenterT. Quang - University of WashingtonJ. Emrich - Hahnemann University HospitalT. Yaeger - Wake Forest UniversityL. Komarnicky - Hahnemann University HospitalL.W. Brady - Hahnemann University Hospital
- Publication Details
- International journal of radiation oncology, biology, physics, v 81(2), pp S180-S180
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine); Medical College of Pennsylvania and Hahnemann University (1993-1996, 1998-2002); [Retired Faculty]; Chemical and Biological Engineering
- Web of Science ID
- WOS:000296411700361
- Other Identifier
- 991019168590104721
Journal article
A Phase II Study of Surgical Excision, Temozolomide, Radiotherapy, and Anti-EGFR Radioimmunotherapy (EXTRA) as Adjuvant Therapy in High-grade Gliomas
International journal of radiation oncology, biology, physics, v 81(2), pp S180-S180
2011
Metrics
7 Record Views
Details
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging